Coissac Patrice 4
4 · ALEXION PHARMACEUTICALS INC · Filed Feb 24, 2012
Insider Transaction Report
Form 4
Coissac Patrice
GM/President ALXN SAS Europe
Transactions
- Exercise/Conversion
Common Stock, par value $.0001 per share
2012-02-23$17.65/sh+90,000$1,588,500→ 175,882 total - Exercise/Conversion
Option to Purchase Common Stock
2012-02-23−5,628→ 0 totalExercise: $17.65From: 2008-04-09Exp: 2017-07-09→ Common Stock, par value $.0001 per share (5,628 underlying) - Exercise/Conversion
Option to Purcahse Common Stock
2012-02-23−84,372→ 0 totalExercise: $17.65From: 2008-04-09Exp: 2017-07-09→ Common Stock, par value $.0001 per share (84,372 underlying) - Sale
Common Stock, par value $.0001 per share
2012-02-23$85.03/sh−90,000$7,652,700→ 85,882 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $84.81 - $85.29. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.